Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • BAC vs GSK✓SelectedUSD · GSKBAC vs GSK performance historyLatest closeAs of-0.70%11/19
Stock and ETF performance explorer

BAC vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+198.7%
GSK return
+97.7%
Excess return
+101.0%
Maximum drawdown
-48.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.7%-1.6%+0.9%-0.2%
7D-3.8%-4.7%+0.9%-2.4%
30D-4.1%-4.7%+0.6%-2.7%
3M-22.7%-8.8%-14.0%-20.7%
6M-3.2%-4.6%+1.4%-2.4%
YTD-10.3%+1.0%-11.3%-11.6%
1Y-4.6%+6.9%-11.5%-7.8%
3Y+74.1%+52.5%+21.5%+42.3%
5Y+20.9%+40.3%-19.4%+0.4%
All+198.7%+97.7%+101.0%+120.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling